Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06414148
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-04-29
Brief Title:
MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
Sponsor:
Peter MacCallum Cancer Centre Australia
Organization:
Peter MacCallum Cancer Centre Australia
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-05
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-29
First Submit QC Date:
May 9 2024
Study First Post Date:
2024-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-08
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL